MALARIA (PLASMODIUM FALCIPARUM)
Clinical trials for MALARIA (PLASMODIUM FALCIPARUM) explained in plain language.
Never miss a new study
Get alerted when new MALARIA (PLASMODIUM FALCIPARUM) trials appear
Sign up with your email to follow new studies for MALARIA (PLASMODIUM FALCIPARUM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Malaria vaccine booster trial aims to keep school kids protected
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a booster dose of the R21/Matrix-M malaria vaccine in 30-40 school children in Burkina Faso who already received four doses years earlier. Researchers want to see if a booster is safe and how well it boosts immunity. Two different booster doses are compared, and …
Matched conditions: MALARIA (PLASMODIUM FALCIPARUM)
Phase: PHASE2 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated May 08, 2026 12:03 UTC
-
Could a cancer drug help beat malaria? new trial aims to find out
Disease control Recruiting nowThis study tests whether adding imatinib (a drug used for certain cancers) to the standard malaria treatment can clear the parasite faster and help stop drug resistance. About 1,100 adults with mild to moderate malaria will receive either the standard 3-day treatment or a shorter…
Matched conditions: MALARIA (PLASMODIUM FALCIPARUM)
Phase: PHASE2 • Sponsor: Victoria Biomedical Research Institute • Aim: Disease control
Last updated May 11, 2026 20:48 UTC